- CEO
- Iain David Worthington Evans
- Full Time Employees
- 203
- Sector
- Finance
- Industry
- Investment managers
- Address
- 16 Palace Street London GL United Kingdom SW1E 5JD
- IPO Date
- Feb 6, 2007
- Business
- Polar Capital Holdings plc is a specialist, investment-led active fund management company that provides professional and institutional investors with a diversified range of equity-focused funds and investment products; these include long-only and alternative strategies such as open-ended UCITS funds, SICAVs, US 40 Act mutual funds, closed-ended investment trusts, and segregated mandates across technology, healthcare, biotechnology, emerging markets, Asia, financials, convertibles, insurance, sustainable themes, Japan, Europe, North America, and UK value opportunities. Core offerings encompass the Polar Capital Global Technology Fund, Artificial Intelligence Fund, Biotechnology Fund, Healthcare Opportunities Fund, Emerging Market Stars Fund, Asian Stars Fund, Global Financials Trust plc, Global Healthcare Trust plc, Polar Capital Technology Trust plc, Smart Energy Fund, Smart Mobility Fund, Global Convertible Fund, Financial Credit Fund, Japan Value Fund, and European ex UK Income Fund, among others managed by specialized investment teams. The company operates from its headquarters at 16 Palace Street, London, United Kingdom, with additional offices in the USA, Spain, Switzerland, France, Germany, China, Singapore, Japan, and Sweden, targeting institutional clients globally with a focus on delivering differentiated risk-adjusted returns through research-driven, entrepreneurial portfolio management.
Founded in 2001, Polar Capital Holdings plc maintains an operational infrastructure supporting fund management, distribution, and client services, with assets under management reaching a record £26.7 billion as of 30 September 2025, up 25% from £21.4 billion six months prior, driven by strong performance in technology and AI strategies amid positive equity markets.
Recent developments include the appointment of Iain Evans as Chief Executive Officer in September 2025 following a planned CEO succession announced in June 2025, along with new leadership appointments in October 2025; strengthening of the Emerging Markets and Asia team in February 2025; launch of the Emerging Markets Healthcare Fund and Financial Credit Fund in 2024; addition of a new International Small and Mid-Cap Equities investment team in February 2024; expansion via a new office in Sweden in 2023 and Switzerland in 2023; and robust net inflows in high-growth funds like Global Technology, Artificial Intelligence, Biotechnology, and Emerging Market Stars, offset by modest outflows in European and UK strategies, with new separately managed accounts established with institutional clients in healthcare and emerging markets during the first half of fiscal 2026.